Fig. 1From: Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to TherapyAdapted from De Palma et al. [19]. Manipulation of chemokine-chemokine receptor signaling pathways could reshape the immune and biological phenotypes of a tumor in a manner that increases effectiveness of immunotherapyBack to article page